Skip to main content
    L

    LENSAR Inc (LNSR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.29
    +0.29 (+5.80%)

    Market Cap: $61.47M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    LENSAR Inc (LNSR) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    LENSAR (LNSR) trades at 1.1x sales and 5.9x book value. Its P/S of 1.1x is below its 5-year median of 1.3x.

    Current Multiples

    Its enterprise value is 2.0x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales1.1x
    Price to book5.9x
    EV/EBITDA2.0x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S1.1x1.3xN/A
    P/B5.9x1.4xN/A
    Medians of month-end values through Oct 2026: 48 to 60 months (5-year).

    Valuation History

    Over the 6 year ends shown, its P/S ranged from 0.9x in 2022 to 2.4x in 2020.

    Year endPriceP/SP/B
    2025$11.632.4xN/A
    2024$8.941.9x21.4x
    2023$3.510.9x1.2x
    2022$2.960.9x0.7x
    2021$5.991.6x1.0x
    2020$7.252.4x0.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About LNSR

    What is LNSR's price to sales ratio?

    LENSAR has a price to sales ratio of 1.1x.